Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Plans Have 15% Margin Of Error In Bids, Consultant Says

Executive Summary

Medicare prescription drug plans will be able to remain profitable in the early years of the drug benefit even if their costs exceed the assumptions underlying their bid by as much as 15%, according to an analysis performed by the Gorman Health Group

You may also be interested in...



Medicare Rx Bids Could Yield 30 Plan Choices Per Region – Schering Exec

Medicare beneficiaries could have 30 choices of Part D drug plans in certain regions based on estimates that CMS received 1,000 bids

Medicare Rx Bids Could Yield 30 Plan Choices Per Region – Schering Exec

Medicare beneficiaries could have 30 choices of Part D drug plans in certain regions based on estimates that CMS received 1,000 bids

Medicare Rx Could Include 150 Part D Plans, CMS Official Estimates

The Centers for Medicare & Medicaid Services anticipates that there will be up to 150 stand-alone Medicare Part D prescription drug plans in 2006, CMS Program Integrity Group Director Kimberly Brandt told the International Pharmaceutical Compliance Summit in Philadelphia April 1

Topics

UsernamePublicRestriction

Register

LL016789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel